Cryoport and Catapult Team up for Gene Therapy Development

CryoPort, Inc., one of the leading global providers of innovative products and services to the fast-growing cell and gene

Stem Pharma Collaborates with Verge Genomics to Treat Parkinson's

Stem Pharm Inc., a drug discovery platform company that leverages

Pharma Industry's Packaging Market To Reach US$246.6 Billion By 2033

The anti-counterfeit pharmaceutical packaging industry is expected to be worth US$ 108.1 billion in 2023 and US$ 246.6 billion in 2033. The market is predicted to increase at an 8.6% annual pace between 2023 and 2033. The growing awareness of...

Indian Pharma Improves Product Development with AI

With data analytics and artificial intelligence (AI), an Indian pharmaceutical company

Purple Biotech Announces Biomarker Data Support For Oncology Drug

Purple Biotech Ltd has announced new biomarker data for oncology drug CM24, a first-in-class anti-CEACAM1 monoclonal antibody. The findings were presented in a scientific poster titled "Phase 1 Study of CM24 in Combination with Nivolumab in...

Rainbow Children's Hospital Signs MoU with Tanzania

Rainbow Children's Medicare Limited (RCML), India's foremost pediatric multi-specialty and prenatal care hospital chain, has signed an MoU (memorandum of understanding) with the Government of Tanzania to establish comprehensive inter...

Aktivolabs Secures HIPAA Certification, Unveils US Operations

Aktivolabs has declared HIPAA compliance and the opening of its US operations. The firm is on a global mission to avoid chronic illnesses. Enterprises and governments may use the real-time digital health platform to create scalable, evidence-based...

Paradigm, Bristol Myers Partners to Build a clinical Trial

Paradigm has announced a partnership with Bristol Myers Squibb to develop a new end-to-end clinical trial operating model that spans design, recruitment, and data collection. Beginning with oncology and eventually expanding to other therapeutic...

Novartis Bags US FDA Approval For Psoriatic Arthritis Treatment

Novartis announced that the US Food and Drug Administration (FDA) has approved Cosentyx (secukinumab) intravenous (IV) formulation for the treatment of adults with psoriatic arthritis (PsA), ankylosing spondylitis (AS), and non...

GSK Inks Shingles Vaccine Deal with Zhifei For $3 Billion

Zhifei, China's largest vaccines producer, will pay British drugmaker GSK 2.5 billion pounds ($3.05 billion pounds) for exclusive distribution rights to GSK's shingles vaccine in the world's No.2 pharmaceuticals market. The agreement is part of a...

© 2025 India Pharma Outlook. All Rights Reserved.